ARTIVION INC (AORT) Stock Price & Overview
NYSE:AORT • US2289031005
The current stock price of AORT is 36.09 USD. Today AORT is down by -2.56%. In the past month the price decreased by -8.84%. In the past year, price increased by 49.63%.
AORT Key Statistics
- Market Cap
- 1.728B
- P/E
- 200.50
- Fwd P/E
- 98.99
- EPS (TTM)
- 0.18
- Dividend Yield
- N/A
AORT Stock Performance
AORT Stock Chart
AORT Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to AORT. When comparing the yearly performance of all stocks, AORT is one of the better performing stocks in the market, outperforming 75.76% of all stocks.
AORT Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AORT. AORT has an average financial health and profitability rating.
AORT Earnings
On February 12, 2026 AORT reported an EPS of 0.05 and a revenue of 115.99M. The company missed EPS expectations (-39.98% surprise) and missed revenue expectations (-2.32% surprise).
AORT Forecast & Estimates
13 analysts have analysed AORT and the average price target is 52.46 USD. This implies a price increase of 45.35% is expected in the next year compared to the current price of 36.09.
For the next year, analysts expect an EPS growth of 102.54% and a revenue growth 11.86% for AORT
AORT Groups
Sector & Classification
AORT Financial Highlights
Over the last trailing twelve months AORT reported a non-GAAP Earnings per Share(EPS) of 0.18. The EPS increased by 141.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.21% | ||
| ROA | 1.1% | ||
| ROE | 2.18% | ||
| Debt/Equity | 0.49 |
AORT Ownership
AORT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.61 | 190.38B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.29 | 174.071B | ||
| SYK | STRYKER CORP | 24.19 | 139.513B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.56 | 105.876B | ||
| IDXX | IDEXX LABORATORIES INC | 41.18 | 48.442B | ||
| BDX | BECTON DICKINSON AND CO | 12.14 | 47.586B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.34 | 47.376B | ||
| RMD | RESMED INC | 20.6 | 36.838B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.63 | 33.849B | ||
| DXCM | DEXCOM INC | 27.04 | 26.209B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11 | 18.413B | ||
| HOLX | HOLOGIC INC | 15.4 | 16.908B | ||
| PODD | INSULET CORP | 37.18 | 16.686B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AORT
Company Profile
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,800 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Company Info
ARTIVION INC
1655 Roberts Boulevard N W
Kennesaw GEORGIA US
Employees: 1600
Phone: 17704193355
ARTIVION INC / AORT FAQ
Can you describe the business of ARTIVION INC?
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,800 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
What is the stock price of ARTIVION INC today?
The current stock price of AORT is 36.09 USD. The price decreased by -2.56% in the last trading session.
What is the dividend status of ARTIVION INC?
AORT does not pay a dividend.
How is the ChartMill rating for ARTIVION INC?
AORT has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the analyst forecast for AORT stock?
13 analysts have analysed AORT and the average price target is 52.46 USD. This implies a price increase of 45.35% is expected in the next year compared to the current price of 36.09.
Can you provide the upcoming earnings date for ARTIVION INC?
ARTIVION INC (AORT) will report earnings on 2026-05-04.